Phreesia, Inc. · Healthcare · Health Information Services
Scores & Status Key
AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$10.72
−$0.18 (−1.61%) 4:00 PM ET
After hours$10.71
−$0.00 (−0.05%) 4:58 AM ET
Prev closePrevC$10.89
OpenOpen$10.75
Day highHigh$11.02
Day lowLow$10.55
VolumeVol608,413
Avg volAvgVol1,078,094
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$673.13M
P/E ratio
71.43
FY Revenue
$495.59M
EPS
0.15
Gross Margin
85.39%
Sector
Healthcare
AI report sections
BULLISH
PHR
Phreesia, Inc.
No AI report section text found yet for this symbol.
Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
A class action lawsuit has been filed against Phreesia, Inc. alleging securities fraud. The complaint claims the company made false statements about its business prospects while experiencing slowing demand, diminished revenue visibility, and weakened pharmaceutical marketing commitments in its Network Solutions segment during the period from May 8, 2025 to March 30, 2026.
The company is the subject of a securities fraud class action lawsuit alleging materially false and misleading statements about business operations, slowing demand, diminished revenue visibility, and weakened pharmaceutical marketing commitments. These allegations indicate significant operational and disclosure failures that harm investor interests.
NegativeGlobeNewswire Inc.• Rosen Law Firm
רוזן, עורך דין מוביל בתחום המשפט, מעודד את משקיעי מיקרוסופט לקבל ייעוץ משפטי לפני המועד האחרון החשוב בתביעה ייצוגית לניירות ערך – MSFT
Rosen Law Firm, an investor rights law firm, is notifying shareholders of Microsoft Corporation and other companies about important deadlines for joining securities class action lawsuits. The firm alleges that Microsoft made false statements regarding its Copilot product line's performance issues, competitive positioning, and failure to convert users to paid subscriptions, resulting in investor losses.
MSFTLCIDPHRsecurities class actionMicrosoftCopilotinvestor lossesdeadline
Sentiment note
A securities class action lawsuit is mentioned with a deadline for investors with losses exceeding $100,000, indicating alleged investor harm and potential securities violations.
NegativeGlobeNewswire Inc.• Rosen Law Firm
PHREESIA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Phreesia, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 13 Deadline in Securities Class Action - PHR
Rosen Law Firm is reminding Phreesia, Inc. investors who purchased stock between May 8, 2025 and March 30, 2026 of the July 13, 2026 deadline to serve as lead plaintiff in a securities class action. The lawsuit alleges that Phreesia made false statements and concealed material facts regarding slowing demand and weakened pharmaceutical marketing commitments in its Network Solutions segment, resulting in investor damages.
PHRsecurities class actionlead plaintiff deadlinefalse statementspharmaceutical marketinginvestor lossesNetwork Solutions segment
Sentiment note
The company is the subject of a securities class action lawsuit alleging false and misleading statements about slowing demand and reduced visibility in key revenue streams, particularly in pharmaceutical marketing commitments. This indicates material misrepresentation that caused investor losses.
PHREESIA, INC. (PHR) INVESTIGATION ALERT: Bernstein Liebhard Announces Investigation of Phreesia, Inc.
Bernstein Liebhard LLP has announced an investigation into whether certain directors and officers of Phreesia, Inc. breached their fiduciary duties to the company. The investigation targets shareholders who purchased shares prior to May 8, 2025. The law firm is seeking affected shareholders to discuss their legal rights and options.
The company is the subject of a formal investigation by a major investor rights law firm regarding potential breach of fiduciary duties by its directors and officers, which raises serious governance and legal concerns for shareholders.
NegativeGlobeNewswire Inc.• The Schall Law Firm
PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm is seeking investors who purchased Phreesia, Inc. securities between May 8, 2025 and March 30, 2026 to join a class action lawsuit alleging securities fraud. The company allegedly made false and misleading statements regarding its long-term growth outlook and fiscal year 2027 projections, particularly regarding pharmaceutical marketing commitments as a growth driver for its Network Solutions segment.
The company is the subject of a securities fraud lawsuit alleging it made false and misleading statements about growth projections and revenue targets, causing investor losses. This represents serious legal and reputational risk.
NegativeGlobeNewswire Inc.• Rosen Law Firm
PHR IMPORTANT DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Phreesia, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 13 Deadline in Securities Class Action - PHR
A securities class action lawsuit has been filed against Phreesia, Inc. for allegedly making false and misleading statements about slowing demand and reduced visibility in key revenue streams, particularly in its Network Solutions segment. Investors who purchased stock between May 8, 2025 and March 30, 2026 and suffered losses exceeding $100,000 are encouraged to join the class action before the July 13, 2026 lead plaintiff deadline.
PHRsecurities class actionPhreesia Inc.investor lossesmisleading statementspharmaceutical marketinglead plaintiff deadline
Sentiment note
The company is the subject of a securities class action lawsuit alleging false and misleading statements regarding slowing demand, reduced visibility in revenue streams, and weakened pharmaceutical marketing commitments. These allegations indicate material adverse facts that caused investor losses.
NegativeGlobeNewswire Inc.• Rosen Law Firm
מועד אחרון לתביעה ייצוגית נגד PHR: רוזן, משרד עורכי דין מוערך, קורא למשקיעי חברת Phreesia, Inc. שספגו הפסדים העולים על 100 אלף דולר לקבל ייצוג משפטי לפני המועד האחרון החשוב ב- 13 ביולי במסגרת תביעה ייצוגית בניירות ערך – PHR
Rosen Law Firm is reminding investors in Phreesia, Inc. who purchased common stock between May 8, 2025 and March 30, 2026 of an important July 13, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Phreesia made false statements and concealed material negative facts regarding declining demand and reduced transparency in revenue sources, particularly in its network solutions segment. Investors who suffered losses exceeding $100,000 are encouraged to seek legal representation.
The company is the subject of a securities class action lawsuit alleging false and misleading statements about declining demand and reduced transparency in revenue sources. Investors suffered significant losses, indicating material misrepresentation of the company's financial condition and business performance.
Deadline Alert: Phreesia Inc. (PHR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
A class action lawsuit has been filed against Phreesia Inc. for allegedly misleading investors about revenue growth projections and risks in its Network Solutions segment. The company announced significantly lowered fiscal 2027 revenue guidance on March 30, 2026, causing the stock to plummet 26.6%. The deadline to file a lead plaintiff motion is July 13, 2026.
The company is the subject of a securities fraud lawsuit alleging it misled investors about revenue growth and risks. Stock price fell 26.6% following the announcement of significantly lowered revenue projections, indicating loss of investor confidence and potential financial misconduct.
NegativeGlobeNewswire Inc.• Rosen Law Firm
PHREESIA DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Phreesia, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PHR
Rosen Law Firm is notifying investors in Phreesia, Roblox, and Zoetis of ongoing securities class action lawsuits. Phreesia investors who purchased stock between May 8, 2025 and March 30, 2026 are reminded of the July 13, 2026 lead plaintiff deadline. The lawsuit alleges that Phreesia made false statements regarding slowing demand and reduced visibility in key revenue streams, particularly in its Network Solutions segment.
PHRRBLXZTSsecurities class actionlead plaintiff deadlineinvestor lossesfalse statementspharmaceutical marketing
Sentiment note
Company is subject to securities class action lawsuit alleging false and misleading statements about slowing demand and reduced visibility in key revenue streams, particularly in pharmaceutical marketing commitments within its Network Solutions segment.
Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
A class action lawsuit has been filed against Phreesia, Inc. alleging securities fraud. The complaint claims the company made false statements about its business prospects while experiencing slowing demand, diminished revenue visibility, and weakened pharmaceutical marketing commitments in its Network Solutions segment during the period from May 8, 2025 to March 30, 2026.
The company is the subject of a securities fraud class action lawsuit alleging materially false and misleading statements about business operations, slowing demand, diminished revenue visibility, and weakened pharmaceutical marketing commitments. These allegations indicate significant operational and disclosure failures that caused investor harm.
NegativeGlobeNewswire Inc.• Holzer & Holzer, Llc
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Graphic Packaging Holding Company (GPK), Immutep Limited (IMMP), and Phreesia, Inc. (PHR) Announced by Holzer & Holzer, LLC
Holzer & Holzer, LLC announced lead plaintiff deadlines for shareholder class action lawsuits against Graphic Packaging Holding Company, Immutep Limited, and Phreesia, Inc. The lawsuits allege materially false statements and/or failure to disclose material facts regarding inventory management, clinical trial status, and long-term growth outlook respectively. Investors who purchased shares during specified periods and suffered losses are encouraged to seek lead plaintiff status by the July 6-13, 2026 deadlines.
GPKIMMPPHRshareholder class actionlead plaintiff deadlinesecurities litigationmaterially false statementsinvestor losses
Sentiment note
Subject of class action lawsuit alleging false/misleading statements regarding long-term growth outlook between May 2025 and March 2026, indicating potential overstatement of company prospects.
NegativeGlobeNewswire Inc.• Holzer & Holzer, Llc
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Graphic Packaging Holding Company (GPK), Immutep Limited (IMMP), and Phreesia, Inc. (PHR) Announced by Holzer & Holzer, LLC
Holzer & Holzer, LLC announced lead plaintiff deadlines for shareholder class action lawsuits against multiple companies including Graphic Packaging Holding Company, Immutep Limited, and Phreesia, Inc. The lawsuits allege materially false or misleading statements regarding inventory management, clinical trial prospects, and growth outlook respectively. Investors who purchased shares during specified periods and suffered losses are encouraged to seek lead plaintiff status.
GPKIMMPPHRshareholder class actionlead plaintiff deadlinesecurities litigationmaterially false statementsinvestor losses
Sentiment note
Subject of class action lawsuit alleging false/misleading statements regarding long-term growth outlook between May 2025 and March 2026, indicating potential overstatement of company prospects.
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal